Related Experiment Video
Updated: Oct 25, 2025

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
miR-301 regulates the SIRT1/SOX2 pathway via CPEB1 in the breast cancer progression
Yanjing Jia1, Jie Zhao2, Jinjie Yang3
1Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, PR China.
Abstract:
Breast cancer, the most common malignant tumor in women, has become a worldwide burden for family and society. MicroRNAs (miRNAs or miRs) are recognized as critical mediators of cancer-related processes, since they have the ability to coordinately suppress multiple target genes. In this study, we aim to find out specific miRNAs involved in the progression of breast cancer and explore the underlying molecular mechanism. Bioinformatics analysis suggested miR-301 as a differentially overexpressed miRNA in breast cancer, which was confirmed by expression determination. Functional assays were employed to explore the effect of miR-301 and its downstream effectors cytoplasmic polyadenylation element-binding protein 1 (CPEB1), SIRT1, and SOX2 on malignant phenotypes of breast cancer. The interaction among these factors was explained using luciferase and RNA immunoprecipitation (RIP) assays. In addition, the in vivo impact of miR-301 on breast cancer was assessed by cellular tumorigenicity in nude mice. We found that miR-301 overexpression restricted CPEB1 level and further promoted cell proliferation, metastasis, and cell cycle progression and impeded apoptosis. Moreover, CPEB1 regulated breast cancer development by mediating the SIRT1/SOX2 pathway. Further, miR-301 overexpression accelerated tumor formation in nude mice. Our results indicate that miR-301 overexpression accelerates the progression of breast cancer through the CPEB1/SIRT1/SOX2 axis.
Insights
MicroRNAs (miRNAs) like miR-301 promote breast cancer progression by inhibiting CPEB1, which regulates the SIRT1/SOX2 pathway. This accelerates tumor growth and metastasis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer is a leading global health concern.
- MicroRNAs (miRNAs) are key regulators of gene expression in cancer.
- Identifying specific miRNAs and their roles is crucial for understanding breast cancer progression.
Purpose of the Study:
- To identify specific miRNAs involved in breast cancer progression.
- To elucidate the molecular mechanisms underlying miR-301's role in breast cancer.
- To investigate the functional impact of miR-301 and its downstream targets on malignant phenotypes.
Main Methods:
- Bioinformatics analysis to identify differentially expressed miRNAs.
- Expression determination and functional assays (luciferase, RIP) to study miRNA-target interactions.
- In vivo studies using nude mice to assess tumorigenicity.
Main Results:
- miR-301 was found to be overexpressed in breast cancer.
- miR-301 overexpression inhibited cytoplasmic polyadenylation element-binding protein 1 (CPEB1) levels.
- miR-301 promoted cell proliferation, metastasis, cell cycle progression, and impeded apoptosis, while accelerating tumor formation in vivo.
- CPEB1 mediated breast cancer development via the SIRT1/SOX2 pathway.
Conclusions:
- miR-301 overexpression accelerates breast cancer progression.
- The miR-301/CPEB1/SIRT1/SOX2 axis is a critical pathway in breast cancer development.
- miR-301 represents a potential therapeutic target for breast cancer treatment.
Related Concept Videos
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs
MicroRNAs
Abnormal Proliferation
Negative Regulator Molecules

